Paolo Tarantino, Research Fellow Dana-Farber Cancer Institute and Harvard Medical Schoolpost, shared a post on X:
“On my way back from JBCS26, reflecting on the closing plenary session: ‘Think globally, act locally’.
Five talks, each carrying distinct geographies and angles, yet all aligned on the common goal to make breast cancer treatment not only effective, but also accessible. Irrespective of the specific conditions.
Michail ignatiadis reviewed the challenges ahead in translating the promise of MRD into an actionable biomarker. We’re not yet there. And it will take a global village to finally get there.
Joana Ribeiro brought the Gustave Roussy perspective, highlighting how improvements in systems of care delivery can matter a great deal in cancer treatment and research.
Gustavo Werutsky reviewed the challenges of navigating the public/private systems fracture in a huge country like Brazil (and all LatAm), with the exceptional efforts of Latin American Cooperative Oncology Group (LACOG) in mitigating disparities
Matteo Lambertini reviewed the many aspects that make care of young patients with breast cancer challenging – yet exceptionally rewarding. POSITIVE brought great hopes in the possibility for safe pregnancies during breast cancer care.
And myself, I tried to provide a global perspective to ADC developments. From a German hypothesis (Ehrlich), to the USA development of T-DM1, to the Japanese revolution of T-DXd, ADCs really required global collaboration to become an available treatment to our patients. Continuing on this path can only lead to further innovation and prognostic improvements.
One major thanks goes to Shigehira Saji, chair of the conference and mind behind this session, and to the Japanese oncology community for being incredibly welcoming.”
Other articles featuring Paolo Tarantino on OncoDaily.